Efficacy of vaccination against severe COVID-19 in relation to Delta variant and time since second dose: the REACT-SCOT case-control study
View ORCID ProfilePaul M McKeigue, View ORCID ProfileDavid A McAllister, Sharon J Hutchinson, Chris Robertson, Diane Stockton, View ORCID ProfileHelen M Colhoun, for the PHS COVID-19 Epidemiology and Research Cell
doi: https://doi.org/10.1101/2021.09.12.21263448
Paul M McKeigue
1Usher Institute, College of Medicine and Veterinary Medicine, University of Edinburgh, Teviot Place, Edinburgh EH8 9AG, Scotland
6Public Health Scotland, Meridian Court, 5 Cadogan Street, Glasgow G2 6QE
David A McAllister
2Institute of Health and Wellbeing, University of Glasgow, 1 Lilybank Gardens, Glasgow G12 8RZ
6Public Health Scotland, Meridian Court, 5 Cadogan Street, Glasgow G2 6QE
Sharon J Hutchinson
3School of Health and Life Sciences, Glasgow Caledonian University. SH - Professor of Epidemiology and Population Health
6Public Health Scotland, Meridian Court, 5 Cadogan Street, Glasgow G2 6QE
Chris Robertson
4Department of Mathematics and Statistics, University of Strathclyde, 16 Richmond Street, Glasgow G1 1XQ
6Public Health Scotland, Meridian Court, 5 Cadogan Street, Glasgow G2 6QE
Diane Stockton
6Public Health Scotland, Meridian Court, 5 Cadogan Street, Glasgow G2 6QE
Helen M Colhoun
5Institute of Genetics and Cancer, College of Medicine and Veterinary Medicine, University of Edinburgh, Western General Hospital Campus, Crewe Road, Edinburgh EH4 2XUC, Scotland
6Public Health Scotland, Meridian Court, 5 Cadogan Street, Glasgow G2 6QE
6Public Health Scotland, Meridian Court, 5 Cadogan Street, Glasgow G2 6QE
Article usage
Posted September 15, 2021.
Efficacy of vaccination against severe COVID-19 in relation to Delta variant and time since second dose: the REACT-SCOT case-control study
Paul M McKeigue, David A McAllister, Sharon J Hutchinson, Chris Robertson, Diane Stockton, Helen M Colhoun, for the PHS COVID-19 Epidemiology and Research Cell
medRxiv 2021.09.12.21263448; doi: https://doi.org/10.1101/2021.09.12.21263448
Efficacy of vaccination against severe COVID-19 in relation to Delta variant and time since second dose: the REACT-SCOT case-control study
Paul M McKeigue, David A McAllister, Sharon J Hutchinson, Chris Robertson, Diane Stockton, Helen M Colhoun, for the PHS COVID-19 Epidemiology and Research Cell
medRxiv 2021.09.12.21263448; doi: https://doi.org/10.1101/2021.09.12.21263448
Subject Area
Subject Areas
- Addiction Medicine (316)
- Allergy and Immunology (621)
- Anesthesia (162)
- Cardiovascular Medicine (2298)
- Dermatology (202)
- Emergency Medicine (371)
- Epidemiology (11623)
- Forensic Medicine (10)
- Gastroenterology (683)
- Genetic and Genomic Medicine (3629)
- Geriatric Medicine (341)
- Health Economics (622)
- Health Informatics (2332)
- Health Policy (919)
- Hematology (336)
- HIV/AIDS (758)
- Medical Education (361)
- Medical Ethics (101)
- Nephrology (394)
- Neurology (3390)
- Nursing (193)
- Nutrition (512)
- Oncology (1777)
- Ophthalmology (526)
- Orthopedics (211)
- Otolaryngology (284)
- Pain Medicine (226)
- Palliative Medicine (66)
- Pathology (441)
- Pediatrics (1013)
- Primary Care Research (410)
- Public and Global Health (6021)
- Radiology and Imaging (1238)
- Respiratory Medicine (814)
- Rheumatology (370)
- Sports Medicine (319)
- Surgery (390)
- Toxicology (50)
- Transplantation (171)
- Urology (143)